Design and in-silico studies of abacavir analogues as Anti-DENV-2 NS5 methyltransferase

Roney, Miah and Mohd Fadhlizil Fasihi, Mohd Aluwi (2025) Design and in-silico studies of abacavir analogues as Anti-DENV-2 NS5 methyltransferase. Letters in Applied NanoBioScience, 14 (2). pp. 1-10. ISSN 2284-6808. (Published)

[img]
Preview
Pdf
Design and in-silico studies of abacavir analogues as Anti-DENV-2 NS5.pdf
Available under License Creative Commons Attribution.

Download (481kB) | Preview

Abstract

Researchers have demonstrated substantial biological activity of the FDA-approved antiHIV drug "abacavir" against the cancer cell line and SARS-CoV-2. Using computational analysis, the most potent abacavir analogs were chosen in this investigation to find an anti-DENV inhibitor against the DENV-2 NS MTase. Twenty-four (24) compounds were collected through the SwissSimilarity program, and four of them were submitted to molecular docking research based on the similarity score (1.000 to 0.400). According to the studies, DB02947 has been identified as a lead molecule against DENV-2 NS5 MTase with a binding affinity of -7.4 kcal/mol and high druggability ratings. To find and discover a novel medicine to treat DENV, in vitro and in vivo experiments on DB02947 are advised to be conducted to ascertain its antiviral efficacy.

Item Type: Article
Additional Information: Indexed by Scopus
Uncontrolled Keywords: Abacavir; Anti-dengue; In-silico; Methyltransferase; Swiss similarity
Subjects: Q Science > QH Natural history > QH301 Biology
R Medicine > RC Internal medicine
R Medicine > RM Therapeutics. Pharmacology
Faculty/Division: Faculty of Industrial Sciences And Technology
Centre for Bioaromatic Research (Bioaromatic Centre)
Depositing User: Mrs. Nurul Hamira Abd Razak
Date Deposited: 18 Jul 2025 01:51
Last Modified: 18 Jul 2025 01:51
URI: http://umpir.ump.edu.my/id/eprint/45105
Download Statistic: View Download Statistics

Actions (login required)

View Item View Item